Literature DB >> 22089118

Predictors of postoperative quality of life after surgery for lung cancer.

Axel Möller1, Ulrik Sartipy.   

Abstract

INTRODUCTION: The aim was to analyze the association between selected patient variables and health-related quality of life 6 months after surgery for lung cancer.
METHODS: In a prospective population-based cohort study, Short Form 36 (SF-36) was used to assess quality of life before and 6 months after surgery for lung cancer. The change in SF-36 summary and subscale scores were used to categorize quality of life in two groups (worse or stable/improved) at 6 months compared with baseline. Logistic regression models adjusting for potential confounding factors were used to analyze the association between patient variables and quality of life 6 months after surgery.
RESULTS: A baseline SF-36 questionnaire was completed by 249 patients. Nonresponders at 6 months (n = 36) were excluded, and 14 patients who died before 6 months follow-up remained in the study, leaving 213 patients available for analysis. Gender, comorbidity, occurrence of postoperative complications, and tumor stage were not associated with the physical aspect of quality of life 6 months after surgery. The extent of resection, age, and adjuvant therapy was significantly associated with a clinically relevant decline in the SF-36 physical component summary score 6 months postoperatively. No patient variables were predictive of a decline in the mental component summary score.
CONCLUSIONS: The extent of resection, age, and adjuvant therapy was associated with a clinically relevant decline in the physical aspect of health-related quality of life 6 months after surgery. Further studies are needed to explore possible mechanisms.

Entities:  

Mesh:

Year:  2012        PMID: 22089118     DOI: 10.1097/JTO.0b013e3182398e82

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  14 in total

1.  A Longitudinal Investigation of Internalized Stigma, Constrained Disclosure, and Quality of Life Across 12 Weeks in Lung Cancer Patients on Active Oncologic Treatment.

Authors:  Timothy J Williamson; Alyssa K Choi; Julie C Kim; Edward B Garon; Jenessa R Shapiro; Michael R Irwin; Jonathan W Goldman; Krikor Bornyazan; James M Carroll; Annette L Stanton
Journal:  J Thorac Oncol       Date:  2018-07-05       Impact factor: 15.609

2.  Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients.

Authors:  Jie Dai; Ming Liu; Stephen J Swensen; Shawn M Stoddard; Jason A Wampfler; Andrew H Limper; Gening Jiang; Ping Yang
Journal:  J Thorac Oncol       Date:  2017-01-23       Impact factor: 15.609

Review 3.  Quality of life after lung resection for lung cancer.

Authors:  Cecilia Pompili
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

4.  Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities.

Authors:  Stacyann Bailey; Qian Wang; Chung Yin Kong; Kimberly Stone; Rajwanth Veluswamy; Susan E Bates; Cardinale B Smith; Juan P Wisnivesky; Keith Sigel
Journal:  Curr Probl Cancer       Date:  2022-05-21       Impact factor: 2.367

5.  Assessment of treatment strategies for stage I non-small cell lung cancer in patients with comorbidities.

Authors:  Keith Sigel; Chung Yin Kong; Amanda Leiter; Minal Kale; Grace Mhango; Brian Huang; Michael K Gould; Juan Wisnivesky
Journal:  Lung Cancer       Date:  2022-05-30       Impact factor: 6.081

Review 6.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

7.  The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer.

Authors:  Mariusz Chabowski; Jacek Polański; Beata Jankowska-Polanska; Katarzyna Lomper; Dariusz Janczak; Joanna Rosinczuk
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities.

Authors:  Keith Sigel; Chung Yin Kong; Sadiq Rehmani; Susan Bates; Michael Gould; Kimberly Stone; Minal Kale; Yeun-Hee Park; Kristina Crothers; Faiz Bhora; Juan Wisnivesky
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

9.  Comparison of single utility port video-assisted thoracoscopic surgery (VATS) and three-port VATS for non-small cell lung cancer.

Authors:  Zhongrui Ye; Bo Zhang; Yu Chen; Jiang Lin
Journal:  Oncol Lett       Date:  2019-05-22       Impact factor: 2.967

Review 10.  Surgical complications and their impact on patients' psychosocial well-being: a systematic review and meta-analysis.

Authors:  Anna Pinto; Omar Faiz; Rachel Davis; Alex Almoudaris; Charles Vincent
Journal:  BMJ Open       Date:  2016-02-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.